AstraZeneca Asserts New Patent In Pulmicort Suit
AstraZeneca Pharmaceuticals LP has asserted a new patent in its suit to prevent Apotex Inc. from launching a generic version of Pulmicort Respules, AstraZeneca's successful asthma treatment for children....To view the full article, register now.
Already a subscriber? Click here to view full article